GUIDELINES, 2026
What the 2026 sepsis guideline says
Summary of a published guideline. Not clinical advice. Follow your local protocol.
The recommendations below are from the Surviving Sepsis Campaign 2026 guideline (SCCM/ESICM, Critical Care Medicine, published 2026-03-23; doi 10.1097/CCM.0000000000007075). Source: SSC 2026 guideline page, recommendation statement. Each line is summarized from the guideline and ends with its strength of recommendation and certainty of evidence.
Surviving Sepsis Campaign 2026
For adults with possible, probable or definite septic shock, or probable or definite sepsis, the guideline recommends antimicrobial therapy immediately, ideally within 1 hour of recognition.
(Strong, very low)
For adults with possible sepsis without shock, the guideline suggests a time-limited course of rapid investigation and, if concern for infection persists, antimicrobial therapy within 3 hours from when sepsis was first suspected.
(Conditional, very low)
For acutely ill patients in hospital, the guideline recommends NEWS, MEWS or SIRS over qSOFA as a single tool to screen for sepsis.
(Strong, moderate)
For adults with septic shock, the guideline recommends an initial mean arterial pressure (MAP) target of 65 mm Hg over higher targets.
(Strong, moderate)
For adults aged 65 or older with septic shock, the guideline suggests an initial MAP range of 60 to 65 mm Hg over higher ranges.
(Conditional, low)
For adults with sepsis-induced hypoperfusion or septic shock, the guideline suggests at least 30 mL/kg of IV crystalloid in the first 3 hours. Remark from the guideline: consider individual patient characteristics.
(Conditional, low)
The guideline suggests early over late source control, ideally within 6 hours of diagnosis of sepsis or septic shock that needs source control.
(Conditional, very low)
Sources read 2026-11-08.
Cited in the Cardiovascular guide
The guide's sources list this guideline. Some pages also cite earlier editions.